Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :

or

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :

or

Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Achaogen Inc - Ordinary Shares AKAOQ

"Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is generated from government contracts for research and development in the United States."

View modes: 

it's a sell today for me

taking my losses here as it is declaring bankruptcy,it's getting pounded today big time,so glta.  rate and reply

added more of this one

using dollar cost averaging for it,should be bottoming out now,over the past month it has been down,so glta shareholders but it is a bargain at these prices.  rate and reply

it's a buy today for me

started a position at these bottom prices and will use DCA for this one,so glta.  rate and reply

waiting for a bottom this month

should be soon for this one,so glta.  rate and reply

watching this one for

a bottom and will be buying when my charts tell me too,so glta.  rate and reply

AKAO Leading Indicators

AKAO leading indicators predicted today's fall of 21% almost 1 month ago.  The predictions were based on a combination of variables.  Stock price, volume, product demand and the...read more

×

StockTalk
Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.